Stelis Biopharma’s CDMO accomplice gets popularity of a key ANDA from the USFDA

Stelis Biopharma’s CDMO accomplice gets popularity of a key ANDA from the USFDA

by admin- Wednesday, December 28th, 2022 04:52:21 PM

 

Stelis Biopharma Ltd (Stelis or Company), an emerging biopharmaceutical Contract Development and Manufacturing Organization (CDMO) and the biologics arm of Strides Pharma Science Ltd stated that its CDMO accomplice has obtained acclaim for a key ANDA from the USA Food & Drug Administration (USFDA).

The submitting for the product changed into completed from Stelis Biopharma’s flagship facility in Bangalore.

News Updates